• In a recent human clinical trial, HYPER-H21-2, DehydraTECH™-CBD reduced arterial stiffness, potentially broadening Lexaria’s application’s ability to treat cardiovascular and other diseases beyond hypertension
• Lexaria’s patented technology DehydraTECH improves how APIs enter the bloodstream –making multiple benefits possible such as increased delivery speed, increase in brain absorbency, higher bioavailability, and lower costs
• The company has patent protection received for delivery of nicotine, vitamins, NSAIDs, terpenes and cannabinoids; and patents pending for delivery of estrogen, testosterone, PDE5 inhibitors, antiviral drugs and more

Oral absorption is the most convenient and widely used administration route for taking medications. Decades of research have advanced the understanding of critical factors – anatomical, physiological, and drug information – which control oral bioavailability. Scientists are now better understanding the physiological function and formulation functionality that has been used in designing better and more desirable oral medicine delivery through extensive research. Lexaria Bioscience (NASDAQ: LEXX), a global innovator of drug delivery platforms, is accomplishing this through its patented DehydraTECH(TM) technology. DehydraTECH(TM) improves the way that active pharmaceutical ingredients (“APIs”) make their way into the bloodstream. This is achieved by promoting healthier ingestion methods and an increase in the effectiveness of fat-soluble active molecules. Lexaria’s DehydraTECH(TM) can be summarized by these major benefits:

• Speeds up delivery
  • The subject feels the effects of the product in as little as a few minutes
• Increases bioavailability
  • The technology is more effective at delivering a drug or other active pharmaceutical ingredient effectively into the bloodstream
• Increases brain absorption
  • Testing suggests greater absorption across the blood-brain barrier
• Improves drug potency
  • A higher proportion of API is made available to the body – allowing for lower doses for similar efficacy
• Reduces drug administration costs
  • Lower doses can mean lower drug costs overall
• Masks unwanted taste
  • The technology eliminates or reduces the need for sweeteners

One of Lexaria’s recent human clinical trials (HYPER-H21-2) using DehydraTECH(TM)-processed cannabidiol (“CBD”) reduced arterial stiffness. The discovery potentially broadens Lexaria’s application’s ability to treat cardiovascular and other diseases beyond hypertension, which had already shown tremendous promise (https://ibn.fm/egW5m). “Reducing arterial stiffness in Lexaria’s recent hypertension study after only a single day of dosing with our DehydraTECH-CBD is a major discovery,” company President John Docherty said, commenting on the results of the study. “We know that increased arterial stiffness is correlated with many serious and life-threatening diseases affecting people worldwide, and we are optimistic that our latest findings could have future widespread implications for the promotion of improved human health and wellness.” To evaluate its technology Lexaria has collaborated with the National Research Council (“NRC”), the Canadian government’s premier research and technology organization. The company has received patent protection for delivery of nicotine, vitamins, NSAIDs, terpenes and cannabinoids; and patents pending for delivery of estrogen, testosterone, PDE5 inhibitors, antiviral drugs and more For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Robert Rositano, the CEO and one of the founders of Friendable, was interviewed by The Los Angeles Tribune in an article published on December 14, 2021
• In the interview, he shared insights into the Fan Pass Live artist platform, what it has achieved so far, and what it plans to accomplish in the future
• He covered the vision behind the platform, the events that led to its formation, and the goals planned for 2022

Friendable (OTC: FDBL), since its inception back in 2014, has remained focused on developing and identifying products, services, and brand opportunities that have mass-market potential and scalability. From launching its first mobile application in the same year, this enterprise has scaled its market reach and diversified its offering to a level where its current market cap stands at just under $2 million (https://ibn.fm/KAltf). Friendable’s current focus is its Fan Pass Live artist platform, a revolutionary approach that offers artists a way to share their music content and make money from it. Artists can make money through fan subscriptions, ticket sales, merchandise sales, and more, all through the platform. Additionally, they can connect to their fans more personally, and fans can enjoy exclusive VIP or backstage experiences right from their smartphones (https://ibn.fm/4R3Xi). While speaking to The Los Angeles Tribune in an article published on December 14, 2021, Robert Rositano, the Chief Executive Officer (“CEO”) and one of the founders of Friendable, got to share the inner workings of the platform. He also provided a background into what led to the platform’s formation, the company’s achievements so far, and what it looks to accomplish in 2022. Mr. Rositano noted that the Fan Pass Live artist platform is an evolution of all that that he and his brother have brought to market in the past. This started from the first company they ever founded, Netcom Online Communications, to America’s Biggest, the first and only video community online that launched two weeks before YouTube (https://ibn.fm/zcA8R). He also expressed his excitement for the 2022 calendar year, for which he noted Fan Pass intends to grow its artist roster to more than 300,00 artists. In addition, the company plans to expand its music distribution and playlisting services while also partnering with venues so fans can also purchase virtual tickets on the platform. “We continue to build on each of our successes and learn more every single day from our artists and that is what it’s all about,” noted Mr. Robert Rositano. “Our team prides itself on being the family all artists need, one in which the relationship goes both ways. It’s not about control, we should succeed together, which is what we are building here with Fan Pass Live,” he added (https://ibn.fm/s4VHB). Fan Pass Live is committed to becoming a true artist partner. Through the decisions made thus far and the strategic investments made by its founders, the platform is accelerating an important transformation in the music industry. You can read the full LA Tribune article here https://ibn.fm/WkL2m For more information, visit the company’s website at www.Friendable.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

Growth Capital Acquisition Corp. (NASDAQ: GCAC), a publicly traded special purpose acquisition company listed on February 2, 2021, with $172.5 million in Trust, and Cepton Technologies Inc., a Silicon Valley innovator and leader in high performance MMT(R) lidar solutions, on August 5, 2021, announced their entry into a definitive business combination agreement. Upon closing of the transaction, the combined company will be renamed ‘Cepton Inc.’ and is expected to be listed on the Nasdaq stock exchange under new ticker symbol ‘CPTN’. The proposed business combination, which has been unanimously approved by the boards of directors of Cepton and Growth Capital, is expected to be completed early in the first quarter of 2022, subject to, among other things, approval by Growth Capital’s stockholders, satisfaction of the conditions stated in the definitive agreement and other customary closing conditions.

• Cepton Technologies Inc. provides highly competitive price-for-performance lidar solutions based on its proprietary Micro Motion Technology (“MMT(TM)”).
• The company was awarded by General Motors the industry’s largest automotive OEM program, with an anticipated start of production set for 2023.
• Cepton has partnered with KOITO, the world’s premier Tier 1 auto lighting supplier, to accelerate product development and enable economies of scale.
• The company boasts a compelling financial profile supported by a capital efficient model leveraging Tier 1 and system integrator relationships, as well as contract manufacturing.
• Cepton is founder-led and guided by management team with a proven track record in advanced lidar and imaging technology.

Cepton Technologies Inc. is a provider of state-of-the-art, intelligent, lidar-based solutions serving a range of markets, including automotive (ADAS/AV), smart cities, smart spaces and smart industrial applications. General Motors (NYSE: GM) has granted a series production award for Cepton’s lidar, the biggest such award to date in the automotive space. Cepton’s is the lidar component of GM’s Ultra Cruise autonomous driving platform. By leveraging its patented Micro Motion Technology (“MMT(R)”) lidar platform, the company develops reliable, scalable and cost-effective solutions that deliver long-range, high-resolution 3D perception for smart applications. Cepton was established in 2016 by co-founders Dr. Jun Pei and Dr. Mark McCord. The company is headquartered in San Jose, California, and serves a fast-growing customer base through an international presence spanning North America, Germany, Japan, India and China. Micro Motion Technology (“MMT(R)”) Cepton was built from the ground up to meet key lidar industry challenges for mass market adoption. This company’s portfolio of proprietary technology is uniquely aimed at facilitating this industry growth through a combination of performance, reliability, affordability and design integration. Key among its innovations is MMT(R), a mirrorless, frictionless, rotation-free 3D imaging platform designed specifically for lidars. Its benefits for OEMs and system integrators include:

• Reliability – The durable design uses common, easily attainable materials
• Versatility – The platform is capable of achieving near- to ultra-long range with a wide field of view
• Efficiency – MMT(R) features a compact form factor, low power usage and inexpensive components
• Scalability – Its simple design means that scale-up to high manufacturing volumes is easily attainable

Because of their compact form factor, Cepton lidars are embeddable and ideally suited for advanced driver-assistance system (“ADAS”) integration, whether behind windshield, in headlamp or in fascia. Agreement with KOITO KOITO Manufacturing Co. Ltd., the world’s premier Tier 1 auto lighting supplier, originally started an evaluation of Cepton’s MMT(R) based lidars in 2018. In 2020, KOITO made an investment in Cepton aimed at accelerating the company’s development and enabling KOITO’s industrialization of high-performance and high reliability lidar sensors for ADAS and autonomous vehicle (“AV”) applications. Through this collaboration, Cepton was able to secure the largest ADAS lidar series production award^[1] with General Motors as a sole source in the automotive space. The award covers GM vehicles for the initial period of 2023-2027. On August 5, 2021, the two companies deepened their relationship when KOITO committed to invest a further $50 million in Cepton’s business through its participation in a Private Investment in Public Equity (“PIPE”) offering of shares of common stock of Growth Capital Acquisition Corp. in connection with Cepton’s proposed merger. Collaboration with GM On July 13, 2021, Cepton announced that it had secured an ADAS lidar series production award from a leading, Detroit-based global automotive OEM – the biggest lidar production award by any OEM to any lidar company. It was later clarified that the OEM was General Motors, and Cepton’s lidar is part of GM’s ADAS Ultra Cruise system. GM is “expected to deploy Cepton lidars in its next generation of advanced driver assistance systems (“ADAS”) across multiple vehicle classes and models – not just luxury cars.” As such, the agreement marks the potential for “an industry-first, mass-market adoption of lidar technology for automotive ADAS, with an anticipated deployment in consumer vehicles starting in 2023.” On July 28, 2021, Ford Motor Company (NYSE: F) distributed an article on Medium noting, “Ford has been engaged with Cepton almost since their inception in 2016, both for R&D collaboration and small-scale deployments. Cepton LiDAR are deployed in some of [Ford’s] smart city projects. Based on Ford’s guidance, Cepton delivered a custom version of their LiDAR to enable R&D on advanced ADAS features.” Market Outlook Driven by increasing development and adoption in automobile safety applications, environmental mapping and 3D-modeling, the global lidar market is forecast to experience considerable growth over the coming years. A research report published by MarketsAndMarkets suggests that the sector will grow to an estimated $3.4 billion by 2026, achieving a CAGR of 21.6% over the next five years. The report further highlights increasing investments in lidar startups by automotive giants as a driver of growth opportunities in the sector, particularly in North America. In 2020, ground-based lidar accounted for the lion’s share of the overall lidar market, and this trend is expected to continue as the automotive sector continues to rapidly advance adoption across the full spectrum of vehicle classes. One factor not to be underestimated is the high barrier of entry and the exceptionally long time required for automotive OEMs to vet and award a production win to a lidar company. It is a commonly held view that the over 50 lidar companies will inevitably coalesce into a handful serving all OEMs. Cepton, having a head start through its established partnership with leading global OEM GM, is uniquely positioned to capitalize on this market growth in the years to come. Management Team Cepton’s founder-led team is made up of lidar industry pioneers with decades of collective experience across advanced lidar and imaging technologies. Jun Pei, Ph.D., is the company’s CEO and Co-Founder. He is a technology specialist with a focus in optics and electronics. Prior to founding Cepton, Dr. Pei founded AEP Technology, a firm focused on developing advanced 3D optical instruments. He received his Ph.D. in electrical engineering from Stanford University. Mark McCord, Ph.D., is Cepton’s CTO and Co-Founder. Prior to founding Cepton, he led advanced development at KLA-Tencor. Dr. McCord also formerly served as an associate professor at Stanford University, where he earned his Ph.D. in electrical engineering. Winston Fu, Ph.D., is the company’s CFO. Dr. Fu is the founder of Silicon Valley venture capital firm LDV Partners. Prior to joining Cepton, he served as CFO and Chairman of Active-Semi before its acquisition. Dr. Fu has also helped to build many technology companies as an entrepreneur and/or board member. He received his Ph.D. in applied physics from Stanford University, as well as an MBA from the Kellogg School of Management at Northwestern University. [1] Largest known ADAS lidar series production award based on number of vehicle models awarded For more information, visit the company’s website at www.GCACorp.com NOTE TO INVESTORS: The latest news and updates relating to GCAC are available in the company’s newsroom at https://ibn.fm/GCAC

• Education and job opportunities are being created for the sector, as more states and more countries around the word are pushing for cannabis legalization
• MCOA offers diverse operations that include both wholly-owned subsidiaries and investment interests, including Cannabis Global Inc., Eco Innovation Group Inc., and Natural Plant Extract
• During Q3 2021, the company saw its highest revenue earning quarter since it became public

Despite challenges posed by the global pandemic, the legalized cannabis market is expected to grow significantly in the next five years. The market was valued at approximately $19.96 billion in 2018, and it is expected to grow at a CAGR of 17.2% during the forecast period, most likely topping $81.47 billion by the end of 2027, according to a recent market forecast report from Transparency Market Research (https://ibn.fm/EuGaN). With more states and countries worldwide pushing for legalization of cannabis, new opportunities are being created specifically for this sector. Most recently, Malta, the EU’s smallest member state, became the first EU country to legalize the cultivation and personal use of cannabis by its citizens (https://ibn.fm/nXxk5). Even colleges and universities are beginning to acknowledge the future of the industry – offering certificate-bearing classes. One example is Syracuse University (“SU”), which has partnered with California-based cannabis education company Green Flower to begin offering students access to certificate programs starting in January. The legalization of cannabis has already shown great promise in New York, creating an additional 77,000 new job opportunities in 2020. “Despite the stigma from the past that still remains around cannabis, the industry itself has an explosive growth pattern that is truly unique and is going to create more opportunities, more jobs, more income and more taxes to the state than any other sector right now,” Green Flower CEO and co-founder Max Simon stated (https://ibn.fm/W8Ucq). Each of the certificate programs will be six months long from start to certification and revolve around different aspects of the cannabis industry, ranging from business, law/policy to medical applications and more. Investing directly in the cannabis sector, Marijuana Company of America (OTC: MCOA) is uniquely positioned to benefit from the cannabis market’s growth and associated opportunities. The company offers diverse operations that include cDistro, one of the THC, hemp, and CBD industry’s fastest-growing distribution companies. MCOA operations also include hempsmart(TM) and VBF brands, a premium CBD company, and a cannabis nursery cultivation facility in Salinas, California, respectively. MCOA is building its portfolio of investments and joint ventures, representing the highest standards of professionalism and integrity in the legal cannabis and the industrial hemp markets. MCOA has partnered with and invested with several cannabis sector leaders, including:

• Cannabis Global Inc. (OTC: CBGL) – this company is considered an emerging force in the cannabis industry, with a growing product and intellectual property portfolio – including the proprietary Comply Bag(TM) and the development/marketing of the Hemp You Can Feel(TM) brand.
• Eco Innovation Group Inc. (OTC: ECOX) – works directly with inventors and other professionals to nurture and catalyze the most innovative and impactful products; Working closely with MCOA to help identify and accelerate the development of new hemp-based products for distribution worldwide.
• Natural Plant Extract (“NPE”) – MCOA holds a direct investment in NPE, which holds a Type 7 California manufacturing and distribution license. This license allows the company to distribute cannabis products anywhere in the state of California.

MCOA recently reported a significant milestone, reaching the highest quarterly revenue numbers since its inception, according to the company’s financial results report for the third quarter, ending September 30, 2021 (https://ibn.fm/s4UPz). “During the third quarter 2021, despite the fact that we have been in the midst of a global pandemic, the Company produced the highest revenues in its history,” CEO Jesus Quintero said, underlining that the company expects to drive continued growth across the entire business the following months. “Our Q3 financial performance was strong and reflects our ability, despite being in a challenging environment, to execute on the strategy by diversifying within the Cannabis industry through strategic acquisitions along with organic growth.” For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com. NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://ibn.fm/MCOA

• As plant-based foods establish a growing market sector, wholesome lifestyle brand builder PlantX Life is expanding its plant-based brick and mortar presence from its flagship Canadian store to outlets in the United States and Israel as well
• PlantX Life is building an e-commerce and plant-based community sustaining presence online through a platform that partners with its growing storefront profile
• The company’s efforts have resulted in record revenues this holiday season, with 63 percent growth during Black Friday and Cyber Monday promotions over last year’s sales during the holiday
• PlantX markets over 5,000 products currently and aims to become a one-stop source for the plant-based community’s needs, not only providing products for sale but information that helps newly arriving consumers adopt a wellness lifestyle and established plant-based community members increase their opportunities

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1), is making a name for itself by combining its mission of plant-based lifestyle education with profit-generating product placement, both through online branding and an attractive storefront profile, and now reports record holiday season sales. PlantX Life has built its Internet retail marketplace with a vision of becoming a one-stop shopping destination for the plant-based community like a vegan Amazon. In tandem with its e-commerce growth, it has established new brick-and-mortar outlets for its branded products in the United States and is expecting to soon open stores in Israel and Canada’s Toronto and Ottawa provinces. PlantX Life has now announced record-breaking revenue from its recently concluded 2021 Black Friday and Cyber Monday promotions. “The increased demand for PlantX products during the recent promotional campaign helped the PlantX achieve a new record revenue of $153,000 in just a few days — an astounding increase from the $0 revenue in 2019 for the same period,” PlantX CEO Lorne Rapkin stated as part of the announcement (https://ibn.fm/7KPQS). The announcement states Black Friday and Cyber Monday revenues grew 63 percent — $60,000 — over last year’s figures. The company’s report noted that the financial results were prepared by management and were not part of the company’s formal auditing procedures, however the business sees the holiday sales growth as an encouraging sign of its strength and is pressing forward to build on the momentum it has achieved. The COVID pandemic has hit economies hard around the world, but businesses such as PlantX Life are drawing on resources developed through e-commerce to boost their brands and seek a connected audience independent of their walk-in store traffic. PlantX’s mission to inform as well as generate revenue underscores its purpose of making the world a better place through its focus on wellness. “A healthy body is one that has a healthy digestive system to break down and absorb all the nutrients it receives,” the company’s blog noted during Halloween as millions of American children were busily gathering candy and store shelves were loaded with the pre-packaged, sugar-and-fat-loaded treats to supply the demand (https://ibn.fm/Gv74q). The company sells over 5,000 products attuned to the needs of the plant-based community, and expects to expand its profile with the addition of cosmetics, clothing and other marketable products that celebrate a wholesome and natural lifestyle. PlantX recently added a subscription service that caters to customer loyalty, providing discounts for automatically renewable weekly, biweekly or monthly product shipments. For more information, visit the company’s websites at www.PlantX.com, www.PlantX.ca, and https://investor.plantx.com/ and view PlantX for Plant-Based Investors. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

• BevCanna Enterprises’ TRACE line of natural alkaline and mineral-infused spring waters have been named as the official water supplier for Vancouver’s 2022 Canadian E-Prix event
• TRACE Natural Alkaline Spring Water, which originates from BevCanna’s wholly owned natural spring water aquifer in British Columbia, are renowned for their optimal mineral content and eco-friendly packaging
• BevCanna will launch a unique, commemorative package for its signature water brand in the run-up to the Vancouver E-Prix
• The event will serve to further propagate the TRACE brand name, with the company already named as the official water supplier to British Columbia’s firefighters

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company developing and manufacturing a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients, has announced that its market-leading TRACE line of natural alkaline spring waters will be the official water supplier of the Canadian E-Prix/2022 Vancouver E-Prix event, which includes the highly anticipated Formula E electric car race (https://ibn.fm/RcDMB). Taking place between June 30 to July 2, 2022, the three-day Canadian E-Fest will welcome the ABB FIA Formula E World Championship to the streets of Vancouver for the first time. The festival will play host to a fan village, feature concerts by two top Canadian musical artists, and to cap it off, will showcase the Formula E electric car race, which will be held on July 2 in Vancouver’s False Creek. BevCanna Enterprises’ TRACE Natural Alkaline and Mineralized Spring Water brand originates in Canada’s Rocky Mountain range, featuring some of the world’s purest water sources. Drawn at the source from a natural aquifer in British Columbia’s Okanagan region, TRACE’s natural alkaline spring water has naturally occurring trace minerals and a 7.7pH, while the mineralized spring waters are infused with fulvic and humic minerals – naturally derived elements which come from decomposed organic matter, and which have been shown to provide benefits to health and the body including boosting the immune system, decreasing inflammation, improving brain function, reducing fatigue, and aiding iron absorption, all while boosting the pH to 8.5pH. Moreover, the alkaline water provides additional benefits to the consumer as compared to most tap and conventional bottled water, including the increased presence of hydroxyl ions, increased hydration, improved bone health, healthier skin and decreased gastrointestinal symptoms (https://ibn.fm/Im17a). The upcoming Vancouver E-Prix event will feature TRACE’s product portfolio of natural and mineralized alkaline spring waters, including the brand’s unique and proprietary mineralized black water. In keeping with the racing festival’s focus on sustainability, TRACE’s products will be packaged in 100% recyclable aluminum cans with TRACE also operating as the Canadian E-Fest’s official recycling partner. To further commemorate the event, TRACE will be launching a special edition Canadian E-Fest branded version of its distinctive aluminum can packaging, featuring a custom Formula E Race logo, with the commemorative can available for sale at leading Canadian retailers in the run-up to the event. “We’re pleased to have been chosen as the official Water Supplier for this unique event,” said Melise Panetta, President of BevCanna. “The Canadian E-Fest event, and especially the Formula E race, will be a highlight of Summer 2022 and we’re thrilled to be a part of it. The Canadian E-Fest’s commitment to sustainability and recycling is significant and we believe it is important to partner on this shared vision.” For more information, visit the company’s website at www.BevCanna.com. NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://ibn.fm/BVNNF

• The Bitcoin Lighting Network, for efficient bitcoin transactions, is seeing more players who are interested in providing an offering that is low fee and instantaneous
• It is estimated that 700 million users will be utilizing the Lightning Network by 2030
• LQwD’s proprietary platform-as-a-service offering is designed to simplify users’ access to the Lightning Network and make it far easier to complete faster, more affordable transactions
• While LQwD remains the only public company focused on Bitcoin Lightning Network, a growing number of companies and entities are becoming interested in leveraging the network’s opportunities

The Lightning Network is becoming a popular way for companies to incorporate Bitcoin into their payment infrastructure. The Lightning Network, as a concept, was first proposed to the public by Joseph Poon and Thaddeus Dryja in 2015 – but has been under development since that time. The Lightning Network is a second-layer technology applied to bitcoin using micropayment channels to essentially scale the blockchain’s capability and conduct transactions quickly and efficiently. With the Lightning Network, users of Bitcoin can say goodbye to the frustrating “mainchain” experience they often deal with when trying to send, receive, or purchase using bitcoin as a payment method. Taking the payments off the main blockchain has allowed for transaction costs to be lower and more efficient overall. As more countries move toward the acceptance of bitcoin as a legal tender (like El Salvador), companies are being required to find ways to accept these payments, and the Lightning Network makes it possible for it to be done without the high number of fees required. This has attracted the interest of several companies and entities ready to leverage the network to both support its growth and their own development. One such company, and so far, the only publicly listed company working with the Lightning Network, is LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a fintech firm focused on creating enterprise-grade infrastructure to drive bitcoin adoption. The company intends to grow the Lightning Network through its proprietary platform as a service (PaaS) lqwd.tech, launched on November 17. The platform was designed to facilitate and simplify access to the Lightning Network, as well as allow users to more easily send payments instantly, securely, and inexpensively anywhere in the world. Upon the platform’s launch, the company deployed a part of its own Bitcoin holdings to procure additional nodes and provide liquidity for the platform. Aiming to empower institutions, businesses, and investors working with the Lightning Network, lqwd.tech was designed to be scalable and adaptive to the fast-paced growth of the Network, allowing for millions of Bitcoin transactions in seconds. The company expects that the Lightning Network will be a force for change globally and become the global monetary exchange of the future. Another company making great strides at incorporating the Lightning Network into its overall infrastructure is CardCoins. CardCoins is a company that allows users to take gift cards and exchange them for Bitcoin. By doing this on the Lightning Network, CardCoins is making transactions simpler and more cost-efficient. As the Lightning Network is being incorporated into various industries, products are being adapted for easier use. One such product is LNURLVend, a device created by developer Ben Arc which essentially works as an offline bitcoin vending machine. The device allows users to buy drinks or sweet treats from a vending machine, using their bitcoin and the Lightning Network (https://ibn.fm/hrZ6h). The operation of it is simple – choose what you want, scan the QR with a Lightning-compatible wallet and then pay, using your PIN for an additional layer of security. “With that, you get a vending machine without an internet connection, and that works with Bitcoin’s Lightning Network, fully functional,” Arc explained his concept. To add perspective on the Lightning Network, recent research from Arcane Research indicated that the number of users on the network is likely to reach 700 million by 2030. Key factors considered by the report include remittance, gaming, streaming, and monetary transaction needs (https://ibn.fm/a76wu). The report also explained how in 2021, wallet use has increased by 20% a month, with the largest numbers coming from regular daily use as opposed to online services. For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

• Mineral property exploration company StraightUp Resources is building a portfolio of gold and silver mining options in Canada, the United States and Peru
• The company has been particularly focused thus far on its options in Ontario, Canada’s prolific Red Lake mining district, where airborne surveys and follow up ground investigation have been completed to analyze site potential
• While gold’s market performance has been lackluster in recent months due to investor skittishness, many analysts predict that inflationary pressures will create a resurgence of gold-hungry activity
• Silver-bullish investors are likewise predicting the metals’ prospects will improve in coming years as a result of a renewed emphasis on green energy

The global COVID pandemic will soon enter its third year. Amid predictions that infections and hospitalizations will drop far enough that the health crisis could lose its pandemic status in 2022 (https://ibn.fm/JEx89), gold-bullish analysts are also anticipating that a huge jump in monetary printing during the past year and a half will continue to drive inflation that could lead the United States into a gold-hungry bear market. “The Fed effectively doubled the US monetary base in just over a year-and-a-half, wildly unprecedented. That deluge added up to an insane $4,492b of new dollars injected into the system in that span,” Adam Hamilton recently wrote for Seeking Alpha. “Gold has spent the past-half year grinding sideways on balance because apathetic investors are missing in action. … Several major gold-bullish catalysts are coalescing around a common linchpin of raging inflation. As this comes to a head, investors’ vexing gold apathy will be shattered. Facing a situation never before seen in market history, they will likely flock back to gold with a vengeance,” he concluded (https://ibn.fm/ueTKn). Silver outperformed gold among investors in 2020, but lost its momentum in 2021. However, some silver-bullish forces predict that a renewed emphasis on green energy sectors expected during the coming years will improve the metal’s appeal. Maria Smirnova of Sprott Asset Management stated in a recent webinar that by 2030 demand from the green energy space, specifically solar panels alone, is estimated to grow by 250 million to 400 million ounces, representing 25 to 40 percent of the entire silver market, The Investing News Network reported (https://ibn.fm/96QSt). “I cannot for the life of me imagine a world in which we can conjure up an extra 300 million ounces of silver just like that. It will be hard work,” Smirnova said in the webinar. “So from that perspective, and again, overlaying the investment demand side of things, we’re quite bullish on silver.” Precious metals explorer and mining property acquisition enterprise StraightUp Resources (CSE: ST) (OTCQB: STUPF) has been increasing its options for gold and silver-potential sites in line with its expectations of the metals’ ongoing potential, building a portfolio during the pandemic era that currently includes the West Cat gold and silver mine in the state of Nevada (United States), options for five gold properties in Ontario, Canada’s well-known greenstone belt (https://ibn.fm/vrjGo), and the potential acquisition of the a historically productive silver mine and processing plant in the Lima region of Peru through a right of exclusivity agreement (“ROE”) with Premier Silver Corp. (https://ibn.fm/1c86l). The eastern Canada properties have commanded the lion’s share of the company’s attention thus far, and interpretation of recent high-resolution heli-borne magnetic surveys (“MAGs”) and the subsequent ground investigation efforts have confirmed “multiple areas of high merit and potential mineralization” (https://ibn.fm/fIGHM) on one of the sites, the Ferdinand Gold Project, which consists of 17 contiguous mining claims covering 7,143 hectares (17,651 acres) at the eastern end of Ontario’s Red Lake mining district. “There is not one Ontario Geological Survey registered drill hole on the entire property,” the company states, adding that government-sponsored magnetic surveys of the site have nonetheless determined that there is a folded stratigraphy along possibly D2 structures, an important geographical feature for gold-bearing hydrothermal fluids and traps (https://ibn.fm/q3kU7). Another of the Ontario sites, the 1,944-hectare (4,803.7-acre) Bear Head Gold Project, is considered particularly significant because historical drilling there in 1989 recorded gold at 11.09 g/t Au over 1.79m, 3.98 g/t Au over 2.3m and 3.08 g/t Au over 2.5m, but the results have not been followed up on by additional drilling (https://ibn.fm/8gkWt). For more information, visit the company’s website at www.StraightUpResources.com. NOTE TO INVESTORS: The latest news and updates relating to STUPF are available in the company’s newsroom at https://ibn.fm/STUPF

• RYAH recently released report highlighting medical cannabis treatment for cancer and adverse effects of cancer treatment
• Data from 80,000 sessions logged between January 1, 2018 and November 15, 2021 tracked conditions including anxiety, cachexia, fatigue, pain, nausea, and stress
• 62% of patients reported a moderate experience using cannabis to treat cancer-related conditions
• RYAH supports cancer research and treatment with IoT product ecosystem comprised of volume-control devices, medicine-carrying components, mobile applications

RYAH Group (CSE: RYAH), the leader in volume-control technology for plant-based medicine, recently released a medical cannabis report on cancer and the adverse effects of cancer treatment (https://ibn.fm/Es52b). Data from 80,000 sessions logged between January 1, 2018, and November 15, 2021, tracked conditions that occur with a cancer diagnosis or are associated with cancer treatments. Conditions highlighted in the report included anxiety, cachexia, fatigue, pain, nausea, and stress. According to the report, patients preferred Sativa and Sativa-dominant strains for anxiety and stress, with an equal split of Indica-dominant and Sativa-dominant strains for pain. Sixty-two percent of patients reported a moderate experience with cannabis, suggesting that respondents found relief from one or more of these symptoms. While there seem to be rising rates of cancer patients exploring cannabis use, according to the report, the evidence collected to date does not currently support this application due in part to a lack of robust, randomized control trials. RYAH’s technology supports cannabis research for the treatment of cancer with innovative technology that collects, analyzes, and leverages objective data on therapeutic plant usage. By using the company’s smart devices and integrated AI-powered platform, patients and doctors can stay on top of prescription treatments in a safe, secure, and seamless way. RYAH’s current portfolio integrates IoT devices, medicine-carrying components, and mobile applications to create an ecosystem that enables practitioners and patients to administer treatments, control volume, collect data, and produce analytics that can power insights for research purposes. Current products in the pipeline include a Smart Dry-Herb Dose-Measuring Inhaler in the commercial stage, a Smart Transdermal Patch in the production stage, and a Smart Liquid Dispensing Pen in the prototype stage. The RYAH Smart Inhaler is a medically certified device under ISO 13485 standards. The device provides consistent and predictable results by allowing users to control and track medicine administration. When connected to the RYAH Health App, practitioners can monitor statistics, temperature presets, and volume amounts to customize treatment and improve results. RYAH’s alternative treatment protocol – the RYAH Smart Transdermal Patch – features a lightweight, reusable, mobile-controlled patch that can be applied for site-specific therapies and controlled with a mobile application to allow scheduled and on-demand “boosting” if required. RYAH’s Smart Pen will leverage a customized multi-component treatment approach with an app-controlled liquid dispenser that allows multiple medicine components to be combined to produce an “entourage effect.” Using cartridges that contain CBD, THC, other cannabis isolates, and vitamins, the Smart Pen controls volume with a built-in mechanism that draws data from a mobile application. RYAH’s doctor collaboration platform, RYAH MD, allows doctors to create digital recommendations for patients and track patient usage for all RYAH IoT devices. RYAH MD will allow doctors to have more oversight on patient use of cannabis products, enabling them to develop highly customized regimens. RYAH holds a unique position at the intersection of the $100.3 billion medical plant market (https://ibn.fm/GVHHK) and IoT and Data Intelligence sectors. As the leading data technology company in plant-based medicine, RYAH is committed to helping researchers produce valuable insights that transform patient care with the power of big data and artificial intelligence. For more information, visit the company’s website at www.RYAHGroup.com. NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://ibn.fm/RYAH

• Mydecine’s and CMPS’ stocks have been grossly undervalued largely due to a lack of understanding of the psychedelic space
• The situation presents a unique opportunity for investment, as Roth Capital Partners issued a $3 buy rating for 2022
• Mydecine has put systems and infrastructure in place to bank on the growing PTSD treatment, smoking cessation, and the health and wellness apps market, in its drive to increase value for its shareholders

There has been a huge misunderstanding of the psychedelic space and the potential that this industry has, specifically regarding the treatment of Post-Traumatic Stress Disorder (“PTSD”) and smoking cessation. This has led to undervalued equities for key players within this space including, but not limited to Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) and Compass Pathways (NASDAQ: CMPS). In October 2021, CMPS released findings from its open-label study of psilocybin therapy to treat depression among cancer patients. Of note was that with a single administration of the COMP360 psilocybin therapy, over half of the patients in the study achieved remission in depression systems, sustained over eight weeks (https://ibn.fm/jLei7). Soon after this important announcement, the value of CMPS stock fell by almost 30%. The drop was attributed to two key aspects. Firstly, traders, as opposed to doctors, read the research and reacted to it negatively. CMPS’ research posted a 50% success rate in treatment-resistant, clinically depressed patients. These patients had to deal with five different clinical treatments with a 0% success rate before achieving a 50% success rate with CMPS. Secondly, the audience lacked the understanding of data and science, prompting them to sell. “People who really did not grasp the significance of the data, they decided to sell,” noted Elemer Piros, an analyst at Roth Capital Partners. CMPS’s challenges also affect Mydecine, an enterprise working towards transforming the treatment of mental health disorders and addiction. Its use of novel psychedelic and non—psychedelic molecules for medical use shows great promise within the industry. Still, the stigma and misunderstanding of the products and what they can achieve comes. As it stands, Mydecine’s stock is trading at $0.16. However, it is one of the few stocks projected to grow tremendously in value in 2022. For one, Mydecine is well-positioned within PTSD treatment, smoking cessation, and the health and wellness apps market, which are valued at a combined $50 billion. It is projected that by 2026, the global smoking cessation market will be valued at $63.99 billion, representing a CAGR of 16.9% over the forecast period (2018-2026) (https://ibn.fm/kOhy2). It is also estimated that the market for psychedelic therapeutics will be valued at $69 billion by 2025, representing a CAGR of 8.2%, indicating the clear growing interest in psychedelic therapeutic drugs (https://ibn.fm/cOxTm). The PTSD market is currently valued at $990 million, with tremendous potential for growth (https://ibn.fm/oOyiD). Tapping into these markets with its technology shows Mydecine’s incredible value. Given its achievements so far and the plans it has already in place, Mydecine is grossly undervalued. This, in turn, presents a huge investment opportunity, a fact that is backed by Roth Capital Partners’ $3 buy rating issue (https://ibn.fm/WEdMU). Mydecine has partnered with the Johns Hopkins University (“JHU”) for its phase 2/3 smoking cessation clinical trial set to launch in early 2022 in what promises to be the company’s most ambitious clinical study yet (https://ibn.fm/7zM0Q). In addition to their seamless phase 2/3 design, Mydecine plans to supply their lead drug candidate, MYCO-001, for Dr. Matthew Johnson’s NIDA grant-funded multi-site smoking cessation study (https://nnw.fm/fomME). With safety and efficacy data from both studies, Mydecine is well positioned to possibly bring a smoking cessation treatment to market as early as 2024. The company has filed a technology patent that allows for the creation of formulations that make use of nano-emulsion technology to enhance, stabilize and make repeatable properties of ingredients from traditional medicine. CEO Josh Bartch stated in a recent press release (https://ibn.fm/07SrX), “The compatibility of these formulas as patent-protected ingredients has Mydecine excited to develop a wide variety of licensing opportunities.” Mydecine’s most recent patent application covers a family of psilocin analogs, psilocybin’s active metabolite, with solutions to directly address precision in delivery control and shelf stabilization (https://ibn.fm/Dwax1). The company believes these improvements will enable safer more effective treatments and ultimately lead to acceptance and adoption of psychedelic medicine. All these moves indicate a company committed to achieving its goals and building value for its shareholders. Moreover, systems and infrastructure so far guarantee the company’s growth in the 2022 calendar year, making it a grossly undervalued company and a viable investment that promises significant returns. For more information, visit the company’s website at www.Mydecine.com. NOTE TO INVESTORS: The latest news and updates relating to MYCOF are available in the company’s newsroom at https://ibn.fm/MYCOF